Skip to main content
Premium Trial:

Request an Annual Quote

Bill Kachioff, Mark Foletta

Bill Kachioff has voluntarily resigned as senior vice president and CFO of Biocept to pursue other business opportunities, the company said. Mark Foletta has been appointed as the company's interim CFO, effective immediately. Foletta previously served as senior vice president and CFO of Amylin Pharmaceuticals from 2000 through its acquisition by Bristol-Myers Squibb in 2012.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.